Key evidence includes the positive effects observed in both organoid models and Atp4a knockout mouse studies.
Analysis involved patient-derived organoids and Atp4a -/- mice to evaluate the impact of taurine on gastric changes.
These findings suggest taurine may help manage gastric intestinal metaplasia, but further research in humans is needed.
Abstract
This study highlights the potential application of taurine as a therapeutic agent for treating GIM, offering a promising strategy for its clinical management.